Published in AIDS Weekly, April 2nd, 2001
J.O. Kahn and colleagues at the University of California, San Francisco, evaluated the results of administering HIV inhibitors to patients reporting high-risk behavior. The results of their research were published in the Journal of Infectious Diseases.
After six months, they found that not a single patient out of the more than 400 studied had developed HIV infection after PEP treatment.
The PEP regimen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.